Scar treatment TRTP-101 tracked for Long-Term safety
NCT ID NCT06435884
First seen Mar 29, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study checks the long-term safety and effectiveness of TRTP-101 in adults with atrophic scars (depressed scars). It follows a small group of 3 people who already received the treatment in an earlier study. Researchers will monitor serious side effects, measure changes in scar volume, and ask patients how satisfied they are with the results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATROPHIC SCAR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Samsung Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.